[PDF] tmrjournals.cn

[PDF][PDF] Systematic evaluation of the efficacy and safety of botulinum toxin type A in the treatment of spastic cerebral palsy

Y Jiang, G Liu, JP Ren - Life Res, 2023 - tmrjournals.cn
Background: Botulinum toxin type A (BTX-A) is a neuromuscular blocking agent. BTX-A
inhibits acetylcholine release, causes neuromuscular transmission impairment, and …
被引用次数：1 相关文章

Systematic evaluation of the efficacy and safety of botulinum toxin type A in the treatment of spastic cerebral palsy.

Y Jiang, G Liu, JP Ren, Y Zhao, HZ Bai… - Life Research …, 2023 - search.ebscohost.com
Background: Botulinum toxin type A (BTX-A) is a neuromuscular blocking agent. BTX-A
inhibits acetylcholine release, causes neuromuscular transmission impairment, and …
[PDF] tmrjournals.com

[PDF][PDF] Systematic evaluation of the efficacy and safety of botulinum toxin type A in the treatment of spastic cerebral palsy

Y Jiang, G Liu, JP Ren - Life Res, 2023 - tmrjournals.com
Background: Botulinum toxin type A (BTX-A) is a neuromuscular blocking agent. BTX-A
inhibits acetylcholine release, causes neuromuscular transmission impairment, and …